Sofosbuvir + Velpatasvir + Voxilaprevir

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandComposition & strengthManufacturer
Sofosbuvir 400mg / Velpatasvir 100mg / Voxilaprevir 100mg tabletsAU ES GB400 mg / 100 mgGilead Sciences Ltd
SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIRUS400 mg / 100 mgGilead Sciences, Inc.
voxilaprevir + sofosbuvir + velpatasvirAU——
沃士維膜衣錠TW
  • tablet Sofosbuvir + Velpatasvir + Voxilaprevir
香港商吉立亞醫藥有限公司台灣分公司
VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottleAU
  • tablet Sofosbuvir 400 mg + Velpatasvir 100 mg + Voxilaprevir 100 mg
Gilead Sciences Pty Ltd
VOSEVI 400 mg/100 mg/100 mg, comprimé pelliculéFR
  • tablet Sofosbuvir 400 mg + Velpatasvir 100 mg + Voxilaprevir 100 mg
GILEAD SCIENCES IRELAND UC (IRLANDE)

Same combination in other markets

These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.